The short version of NMN fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-01-14. Anything still debated is marked as such rather than presented as settled.
NMN is present in small amounts in various foods, including certain vegetables, fruits, and milk, though dietary quantities are generally low. Laboratory research often uses synthetic or enzymatically produced NMN. The compound has drawn interest because NAD+ levels decline with age in some tissues and because restoring NAD+ may affect metabolism in animal models. Whether oral NMN produces meaningful NAD+ increases in humans and whether such changes translate into health benefits are not fully established.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide base with a ribose sugar and a phosphate group. Within cells, NMN sits on the biosynthetic route that recycles nicotinamide back into nicotinamide adenine dinucleotide, or NAD+. Because NAD+ participates in redox reactions and signaling, enzymes that produce and consume it influence many metabolic processes. The compound is therefore best described as an intermediate rather than a final signaling molecule.
Terminology around NMN can be confusing because several related compounds share the vitamin B3 family. Nicotinamide riboside is a nucleoside, whereas NMN is a nucleotide with a phosphate group, and NAD+ is a dinucleotide coenzyme rather than a simple precursor. Niacin and nicotinamide are also NAD+ precursors but follow different metabolic entry points. In commercial and scientific writing, NMN usually refers to beta-nicotinamide mononucleotide unless another form is specified. Consistent nomenclature helps distinguish chemical identity from proposed biological effects.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a pyridine nucleotide that consists of a nicotinamide ring, a ribose sugar, and a phosphate group. It is an intermediate in the salvage pathway for nicotinamide adenine dinucleotide, or NAD+, synthesis. In mammalian cells, the enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. Nicotinamide mononucleotide adenylyltransferases then convert NMN into NAD+. The core structure and enzymatic route are well established in biochemical literature.
| Property | Value | Notes |
|---|---|---|
| Chemical name | Nicotinamide mononucleotide | Abbreviated NMN |
| Molecular formula | C11H15N2O8P | Neutral form |
| Molar mass | 334.22 g/mol | Approximate value |
| Appearance | White to off-white powder | Typical solid form |
| Solubility | Water-soluble | May absorb moisture |
Two enzymatic steps define the canonical route from nicotinamide to NAD+. Nicotinamide phosphoribosyltransferase, known as NAMPT, produces NMN from nicotinamide and phosphoribosyl pyrophosphate. NMN adenylyltransferases, or NMNAT enzymes, then couple NMN with ATP to form NAD+. Whether intact NMN crosses cell membranes efficiently remains an active area of investigation; some studies propose direct transport, while others emphasize extracellular dephosphorylation to nicotinamide riboside followed by uptake. The relative contribution of each route likely depends on cell type, tissue, and experimental conditions.
Trace amounts of NMN have been reported in certain plant foods, including edamame, avocado, broccoli, cucumber, and cabbage. Reported concentrations vary widely because analytical methods differ and food matrices complicate extraction. Endogenous production in cells is generally considered more quantitatively important than dietary intake, though precise human turnover rates are difficult to establish. Commercial NMN for research or consumer products is commonly made through enzymatic synthesis or chemical phosphorylation routes. Regulatory classification differs by country; in some jurisdictions NMN is sold as a supplement, while in others it is treated as a novel food ingredient or restricted substance.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in cells. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. As an intermediate in the NAD+ salvage pathway, NMN is converted to nicotinamide adenine dinucleotide, a coenzyme central to cellular redox reactions. NAD+ also serves as a substrate for enzymes involved in DNA repair, stress responses, and metabolic regulation. The compound is therefore part of normal cellular biochemistry rather than an exclusively synthetic molecule.
Small amounts of NMN occur in some foods, including certain vegetables, fruits, and animal products, though the quantities are generally low and variable. Human cells also synthesize NMN internally from nicotinamide and other precursors. Research interest increased after studies examined whether raising NAD+ levels affects metabolism and aging-related pathways in animals. Evidence in humans remains limited and mixed for many outcomes, and questions about effective absorption, tissue delivery, and long-term effects are still open. Regulatory status differs by country, with some markets treating NMN as a supplement ingredient and others restricting its sale.
Nicotinamide mononucleotide, usually shortened to NMN, is a naturally occurring nucleotide. Its structure consists of a nicotinamide base linked to a ribose sugar that carries a phosphate group. In cells, NMN serves as an intermediate in the salvage pathway that produces nicotinamide adenine dinucleotide, or NAD+. Because NAD+ participates in many oxidation-reduction reactions, NMN sits near central metabolic processes. The compound is not a drug in most jurisdictions and is discussed mainly in biochemistry and nutrition research.
Natural sources of NMN include mammals, plants, and microorganisms, where it functions as an intermediate in NAD+ salvage and biosynthesis pathways. In mammals, the enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferase. Some foods contain measurable NMN, but reported amounts vary widely by species, tissue, and analytical method. The extent to which dietary NMN contributes to cellular NAD+ pools remains an open research question.
Chemically, NMN is described by the molecular formula C11H15N2O8P and a molecular mass near 334.22 g/mol. The beta anomer has a CAS Registry Number of 1094-61-7. It is typically supplied as a white to off-white powder for laboratory use. The molecule carries a phosphate group and a positively charged nicotinamide ring, giving it polar and water-soluble character. These properties influence how it is detected, purified, and stored in research and analytical laboratories.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in cells. Its structure consists of a nicotinamide ring linked to ribose phosphate, and the compound serves as an intermediate in the salvage pathway for nicotinamide adenine dinucleotide, or NAD+. In this pathway, nicotinamide phosphoribosyltransferase converts nicotinamide and phosphoribosyl pyrophosphate into NMN, after which NMN adenylyltransferase attaches an adenylate group to produce NAD+. Because NAD+ participates in redox reactions and signaling, NMN occupies a central position in cellular metabolism. The molecule is distinct from nicotinamide riboside, though the two are related in NAD+ precursor research.
Beyond its intracellular synthesis, NMN can be taken up from the extracellular environment, although the routes are still debated. Some evidence points to direct transport into cells through specific transporters, while other work suggests dephosphorylation to nicotinamide riboside followed by cellular uptake. Once inside, NMN can be converted to NAD+ by NMN adenylyltransferases; the relative contribution of these routes may differ by tissue, species, and experimental conditions. Researchers continue to investigate which mechanisms dominate in intact organisms and how they affect measured NAD+ levels. Direct measurement in tissues remains technically challenging because NMN can be rapidly metabolized during sample collection.
=== Mating === When ready to mate, cabbage loopers display by elevating their abdomen and fanning their wings. Males also fan out their abdominal hairs, open their genital claspers, and partially stick out their spermatophores. Males gradually expose more of their spermatophores as they wait for a mate. Upon interest, a potential mate examines the other's abdomen with antennae, and mating occurs if both agree. Mating on average occurs at 2am, but has been observed occurring between 12 and 4am. Mating generally occurs 3–4 days after emergence, but can occur up to 16 days afterwards. Usually, mating does not occur before the third day, as eggs are not fully developed upon emergence and require a few days to reach maturity. Multiple matings is a mating strategy where individuals have multiple mates in their lifetime. This is in contrast to monogamy, where individuals have one mate for life. Mating multiply can be advantageous to both sexes, which is why this strategy has evolved in many species, including the cabbage looper. For female cabbage loopers, rate of oviposition increases with the number of matings, and ultimately lay more eggs total. While it was once believed that multiple matings were necessary to fertilize all eggs, evidence shows that only one mating is needed to fertilize almost all eggs. Instead, it is more likely that the spermatophore provides nutrients to the female that confers reproductive benefits. This may explain why males produce female-attracting pheromones, as females may be seeking nutrient-rich spermatophores.
With mutual arrangement with Leuven, he became professor in both universities from 1962, dividing his time between Leuven and New York. In 1974, the same year he received his Nobel Prize, he founded the ICP, which would later be renamed the de Duve Institute. He became emeritus professor of the University of Louvain in 1985, and of Rockefeller in 1988. De Duve was granted the rank of Viscount in 1989 by King Baudouin of Belgium. He was also a recipient of Francqui Prize, Gairdner Foundation International Award, Heineken Prize, and E.B. Wilson Medal. In 1974, he founded the International Institute of Cellular and Molecular Pathology in Brussels, eventually renamed the de Duve Institute in 2005. He was the founding President of the L'Oréal-UNESCO For Women in Science Awards. He died by legal euthanasia after long suffering from cancer and atrial fibrillation.
=== EC 1.1.2 With a cytochrome as acceptor === EC 1.1.2.1: glycerolphosphate dehydrogenase. As the acceptor is now known, the enzyme has been transferred to EC 1.1.5.3, glycerol-3-phosphate dehydrogenase. EC 1.1.2.2: mannitol dehydrogenase (cytochrome) EC 1.1.2.3: L-lactate dehydrogenase (cytochrome) EC 1.1.2.4: D-lactate dehydrogenase (cytochrome) EC 1.1.2.5: D-lactate dehydrogenase (cytochrome c-553) EC 1.1.2.6: polyvinyl alcohol dehydrogenase (cytochrome) EC 1.1.2.7: methanol dehydrogenase (cytochrome c) EC 1.1.2.8: alcohol dehydrogenase (cytochrome c) EC 1.1.2.9: 1-butanol dehydrogenase (cytochrome c) EC 1.1.2.10: lanthanide-dependent methanol dehydrogenase EC 1.1.2.11: glucoside 3-dehydrogenase (cytochrome c)
== Criticism and decline == In June 2019 a counter-subreddit, r/CantelmoismExposed, was created. Its moderators and other users criticized the medical claims, the targeting of younger Reddit users, the encouragement of practices such as staring at the sun, and what they described as cult-like dynamics. Cantelmo’s responses to critics sometimes included insults. In one AMA he told a skeptical cancer patient to “fuck off.” Cantelmo’s main Reddit account was banned in July 2019 for harassment, including the doxxing of a mental-health professional who had contacted authorities after Cantelmo made suicidal statements. Cantelmo continued posting from alternate accounts. He also directed hostility toward family members and former friends who expressed concern about his mental state and spending. By late 2019 the volume of award-giving had decreased as funds were depleted. Many participants who had been drawn by the awards became less active. Cantelmo’s brother later stated that Cantelmo had spent a large portion of his retirement savings. James Kent, writing in 2022, cited Cantelmo’s case in a discussion of the risks of frequent DMT use, noting reports of psychosis, grandiose delusions, and detachment from reality associated with multiple daily sessions over extended periods.
== Research == Current research in regenerative medicine spans a continuous spectrum from fundamental cell biology to clinical translational engineering, focusing on deciphering and manipulating the signaling pathways that govern tissue morphogenesis, cellular differentiation, and scarless wound healing. Rather than merely managing chronic symptoms, active laboratory investigations aim to understand why adult mammalian tissues lose the regenerative capacities inherent in lower vertebrates and human embryonic states. Research strategies are broadly categorized into three interdependent vectors: cell-based therapies, which isolate and direct stem cell fates; biomaterial design, which engineers bioactive scaffolds to mimic the native extracellular matrix; and the delivery of localized biochemical cues, such as growth factors and gene-editing complexes, to orchestrate endogenous tissue repair. A major bottleneck in ongoing research is solving the scalability of functional vascularization, as complex engineered tissues cannot survive past the limits of oxygen diffusion without an integrated capillary network.
Sources: en.wikipedia.org
=== Names === Vosilasarm is the generic name of the drug and its International Nonproprietary Name (INN). It is also known by its pharmaceutical developmental code names RAD140 (Radius Health) and EP0062 (Ellipses Pharma). Additionally, vosilasarm is known by the black-market name Testolone or Testalone.
=== Portal: Companion Collection === Portal: Companion Collection is a compilation of both games and Still Alive content released for Nintendo Switch on June 28, 2022. The port was developed in collaboration with Nvidia Lightspeed Studios.
== Spikes to Stability: Trelagliptin Minimizes Glycemic Variability == Trelagliptin, a once-weekly DPP-4 inhibitor, helps manage glycemic variability (GV) in type 2 diabetes. It works by prolonging the activity of incretins (GLP-1 and GIP), which enhances insulin secretion and suppresses glucagon release in a glucose-dependent manner. This action helps reduce [[[postprandial hyperglycemia]] and smooth out daily blood glucose fluctuations. Continuous glucose monitoring shows improved glycemic stability with lower glucose variability. Trelagliptin also lowers the risk of hypoglycemia due to its glucose-dependent effects. By reducing GV, it helps prevent damage to blood vessels. This ultimately lowers the risk of cardiovascular complications in diabetic patients.
=== Proteins === Proteins present in the hemolymph vary in quantity during the course of development. These proteins are classified by their functions: chroma proteins, protease inhibitors, storage, lipid transport, enzymes, the vitellogenins, and those involved in the immune responses of arthropods. Some hemolymphic proteins incorporate carbohydrates and lipids into the structure.
Sources: en.wikipedia.org
NMN is nicotinamide mononucleotide, a nucleotide intermediate in NAD+ biosynthesis. It occurs naturally in cells and is also produced commercially as a supplement ingredient.
No. NMN is a precursor that can be converted into NAD+, while NAD+ is a dinucleotide coenzyme involved in redox reactions and signaling.
Small amounts have been reported in foods such as edamame, avocado, broccoli, and milk. Dietary amounts are generally much lower than those used in research studies.
NMN stands for nicotinamide mononucleotide. It is a naturally occurring nucleotide intermediate in NAD+ biosynthesis.